Cancer Gets Personal at IU Health Precision Genomics

Posted: Updated:
IU Precision Genomics leaders cut the ribbon to open a new clinic inside the Simon Cancer Center in Indianapolis. IU Precision Genomics leaders cut the ribbon to open a new clinic inside the Simon Cancer Center in Indianapolis.

A building doesn’t make a center, but the early and swift success of a young cancer treatment program at Indiana University Health demanded more space. IU Health Precision Genomics focuses on patients with late-stage cancer who have exhausted standard treatment options, and the program recently moved into a new center that is opening the door to more patients. Indianapolis resident Gwen Brack credits the new approach to cancer treatment for saving her life after she was diagnosed in her twenties with a colorectal cancer that was slowly beating down her body.

Brack says her college student life was “completely turned upside down” when doctors diagnosed her with late-stage colorectal cancer when she was just 21 years old. She had success with standard treatments, but it wasn’t long-lasting; the cancer repeatedly came back and spread to multiple organs.

The elusive disease demanded a different treatment—something more personal—and that’s what IU Health says precision genomics offers. The only program of its kind in Indiana, it sequences a patient’s entire genome, which is 22,000 genes, and the patient’s tumor to create “a hyper-personalized” treatment plan.

“There are 22,000 genes that tell our bodies what to do; it’s the blueprint for how we operate as a person,” says IU Health Precision Genomics Executive Director Will Hundley. “Precision genomics looks at those 22,000 individual genes and says, ‘This gene is causing this problem for Will. Is there anything we can do to that specific gene to improve Will’s cancer diagnosis?’”

Hundley says other programs typically only analyze about 360 genes, but notes IU Health Precision Genomics is one of only a few in the nation sequencing the entire genome. A study authored by the program’s leaders showed that 43 percent of patients with late-stage cancer who were treated with precision genomics showed meaningful improvement in survival without progression of cancer, compared to just 5 percent of patients with late-stage cancer who were treated with non-precision guided therapy.

Patients with stage three or four cancer who have not had success with traditional treatment are referred to the program by their oncologists. After a patient’s personal genome is sequenced and the tumor’s genetics analyzed, Hundley says a panel of experts—“unbelievably talented people”—examines each case individually and recommends a treatment plan.

“These 20 thought leaders are a multitude of oncologists with different specialties, folks from radiology and the pathology lab. It’s another unique feature of our program—that a patient and their information is presented to such a prestigious group of folks for final analysis and sign-off on the action plan,” says Hundley. “They are so fond of being together as a group that it just has a momentum and life of its own that’s really productive for patients.”

The program started informally in 2014 and by 2017 was working with 400 to 500 patients. In early 2018, the health system invested in new space to continue growing precision genomics. It recently opened a clinic inside the Simon Cancer Center in Indianapolis; leaders expect the expansion will enable the program to work with about 650 patients in 2018. The growth includes satellite locations in Lafayette, Bloomington, Muncie and Carmel.

Hundley says, because the precision genomics field is in its infancy and the “science is changing daily,” patients will undergo standard cancer treatments first.

“We’re very early in the journey. In oncology right now, we know about 600 of the genes and their implications in the disease state,” says Hundley. “New clinical trials now are gene-based, instead of location-based; in the past, there would’ve been a breast cancer trial, now, there will be a gene trial based on a specific gene. The amount of information is changing every day, and those studies are just ramping up to a critical mass.”

For Brack, precision genomics uncovered a shocking solution: a simple daily dose of aspirin is a more effective treatment for her cancer than chemotherapy. She’s been cancer-free for one year.

“[Aspirin] is something that has been shown to work for my particular cancer—not just any colorectal cancer, but mine,” says Brack. “Hope is an integral part of the precision genomics program; it’s that next chance when you’ve exhausted the protocol drugs. It’s given me hope, given me a future, and literally, is life-saving. It’s going to change the future of cancer medicine.”  

Brack says she found it comforting that a panel of experts analyzed her case to find the best treatment for her personally.
Hundley says it’s inexpensive for a patient to go through the precision genomics process.
Hundley says the center also emphasizes research.
  • Perspectives

    • What's Your College Student's Financial Intelligence?

      Do you have a child who’s headed to college - or maybe already attending?  If there was a financial intelligence exam, you would want your student to ace it!  Help your student develop good money management skills. That knowledge will pay dividends for a lifetime! For most students, going off to college is the first time they’ll be on their own. It’s imperative that they learn to be responsible for themselves. As parents, we hope any lapse in personal...



Company Name:
Confirm Email:
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections


  • Most Popular Stories

    • National Guard Academy Targets At-Risk Youth

      Indiana's adjutant general says the Hoosier Youth Challenge Academy in Knightstown continues to make a difference by offering at-risk teenagers a second chance. The academy, which was established in 2007, will Saturday celebrate another graduating class. The program uses quasi-military training, structure and discipline for students between the ages of 16 and 18 who have dropped out of school or are severely deficient in credits. In an interview on Inside INdiana Business...

    • IIB Hires Merritt McLaughlin

      Grow INdiana Media Ventures LLC, the parent company of Inside INdiana Business, has hired Merritt McLaughlin as writer/reporter. McLaughlin is a recent Ball State graduate who has previously worked as a writer for Indianapolis Monthly and Ball State's Ball Bearings Magazine. The New Hampshire native has won several writing awards from organizations including the Columbia Scholastic Press Association, Indiana Collegiate Press, the Ball State Department...

    • Study: State Fairgrounds Impact Grows

      A new study shows the economic impact of the Indiana State Fairgrounds has grown. The study, conducted by the Indiana University Kelley School of Business, says events at the fairgrounds as well as the renovation of the Indiana Farmers Coliseum generated a direct economic impact of more than $197 million on the local economy in 2017, more than 22 percent higher than the previous study in 2011. The study says $152 million came from visitors to Indianapolis. Attendees of the...

    • South Bend Mayor Not Seeking Re-Election

      The mayor of South Bend says he will not seek a third term. Pete Buttigieg, whose current term ends in just over a year, said during a news conference Monday his administration will continue to work hard during that time "to accomplish our mission to deliver services that empower everyone to thrive."

    • $600M Waste-to-Fuel Plant Coming to Gary

      A California-based renewable jet fuel and diesel producer has announced plans for a massive investment in northwest Indiana. Fulcrum BioEnergy Inc. says it will invest $600 million to build the Centerpoint BioFuels Plant in Gary, which will convert municipal solid waste into renewable transportation fuel. The project is expected to create up to 163 jobs by the end of 2022. The Indiana Economic Development Corp. says Centerpoint will be located at an industrial site that will be...